|
CN106474067A
|
|
A kind of polyethyleneglycol modified gemcitabine or its liposome of salt and its preparation method and application
|
|
CN106317075A
|
|
Preparing method of Cefsulodin
|
|
CN106008301A
|
|
26-methyl-25-hydroxyvitamin D3 compound and preparation method and application thereof
|
|
CN105919974A
|
|
Salmon calcitonin-phospholipid complex and its lipid nanoparticle and preparation method
|
|
CN105820213A
|
|
Method for efficiently separating and purifying pnemocandin
|
|
CN105832665A
|
|
Itraconazole/phospholipid composite and preparation method thereof, itraconazole sub-micro-emulsion, preparation method and application thereof
|
|
CN105796532A
|
|
Rabeprazole sodium sustained-release capsule and preparation method thereof
|
|
CN104910192A
|
|
Preparation of impurity in cefetecol disodium and structure confirmation method
|
|
CN104931603A
|
|
Method for measuring fudosteine related substance by using amino column
|
|
CN104817600A
|
|
Preparation and purification method of dihydro hyper erythrocin
|
|
CN104788520A
|
|
Preparation and purification method of erythromycin oxime
|
|
CN104774834A
|
|
Method for screening daptomycin high-producing strain by adopting sodium glutamate tolerance model
|
|
CN103664774A
|
|
Preparation method for pitavastatin calcium intermediate
|
|
CN103641845A
|
|
Preparation method of cefatrizine propylene glycol
|
|
CN103898004A
|
|
Pseudonocardia and method thereof for producing calcifediol by fermentation
|
|
CN103508896A
|
|
Nitric monoxide donor derivatives of Bexarotene, and preparation method thereof
|
|
CN103396422A
|
|
Cephalosporin compound and preparation method thereof
|
|
CN103396423A
|
|
Preparation method of powdery disodium cefotetan
|
|
CN103342708A
|
|
Method for preparing propylene glycol cefatrizine 3-locus intermediate
|
|
CN103193800A
|
|
Method for separating and purifying various components from cefaclor enzymatic reaction solution
|
